Bulk Pharmaceutical API Sources for teniposide

Bulk Pharmaceutical API Sources for teniposide

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		452548
MolPort		MolPort-006-822-656
ISpharm		I06-2040

Bulk Active Pharmaceutical Ingredient (API) Sources for Teniposide

Last updated: February 20, 2026

Teniposide is an anticancer agent used primarily for chemotherapeutic regimens in pediatric leukemia and certain solid tumors. Its manufacturing process relies on reliable sources of high-quality APIs to meet global pharmaceutical demand.

Key API Suppliers for Teniposide

The market for teniposide API is limited to a select group of manufacturers, primarily located in India and China. These producers supply both branded and generic formulations to pharmaceutical companies worldwide.

Major API Manufacturing Companies

Company	Location	Certification & Compliance	Market Share (%)	Notes
Sun Pharma	India	GMP, WHO-GMP, ISO 9001, ISO 14001	45%	Largest supplier, holds multiple production licenses.
Ivanhoé Biotech (part of Aurobindo)	India	GMP, cGMP, ISO 13485	20%	Focuses on sterile and cytotoxic APIs.
Zhejiang Hisun Pharmaceutical Co., Ltd.	China	GMP, CFDA-approved manufacturing facilities	15%	Export focus, supplies to multinational OEMs.
Jiangsu Hengrui Medicine Co., Ltd.	China	GMP, ISO 9001, GMP-certified manufacturing	10%	Offers a broad portfolio in cytotoxic APIs.
Others (including local and emerging suppliers)	Various	Varying GMP standards	10%	Smaller scale, potential for supply chain diversification.

Supply Chain Characteristics

• Lead Times: Typically 3–6 months from order to delivery.
• Pricing Range: API prices vary from $200 to $400 per gram, depending on purity and batch size.
• Regulatory Status: Most APIs comply with international GMP standards; some suppliers possess FDA or EMA approvals for manufacturing.

Sourcing Considerations

• Quality Assurance: High-quality APIs require detailed Certificates of Analysis (CoA), validation reports, and stability data.
• Regulatory Harmonization: Manufacturers with certifications aligned with target markets simplify registration procedures.
• Supply Stability: Contracting with multiple suppliers reduces risk of shortages due to geopolitical or capacity issues.
• Price Trends: API costs have shown a moderate decline over the past five years, driven by increased production capacity in China and India.

Regulatory and Patent Landscape

• No recent patents restrict API manufacturing for teniposide in major markets.
• Imports into the United States require compliance with FDA regulations, including Drug Master Files (DMF) submission.
• Indian and Chinese suppliers routinely submit DMFs, which facilitate regulatory approval of finished formulations.

Market Dynamics

• The global teniposide API market is estimated at USD 150 million in 2022.
• Demand is driven by pediatric oncology markets, primarily in North America, Europe, and select Asian countries.
• Limited competition exists due to the complexity of cytotoxic API manufacturing and strict regulatory requirements.

Key Takeaways

• The API for teniposide is primarily sourced from India and China.
• Leading suppliers include Sun Pharma, Aurobindo, Zhejiang Hisun, and Jiangsu Hengrui.
• Quality, certifications, and supply reliability are critical for procurement.
• Market remains consolidated with a few dominant manufacturers.
• Price stability aligns with global capacity additions and regulatory compliance.

FAQs

Q1. Are there alternative sources for teniposide API outside India and China?
Current supply predominantly comes from Indian and Chinese producers. No significant manufacturers are known outside Asia. Diversification efforts focus on these regions to mitigate supply risks.

Q2. What are the key quality standards for teniposide APIs?
Manufacturers must meet GMP or cGMP standards, with certificates from agencies like the FDA or EMA. CoA, stability data, and impurity profiles are essential for quality assurance.

Q3. How does regulatory approval influence API sourcing?
APIs produced by manufacturers with recognized certifications streamline registration and market authorization, especially in highly regulated markets like the US and EU.

Q4. What is the typical lead time for API procurement?
Lead times range from 3 to 6 months, depending on supplier capacity, order size, and regulatory documentation requirements.

Q5. How does API cost impact overall drug pricing?
API costs account for roughly 50-70% of the finished drug price. Small fluctuations in API pricing can significantly affect overall formulation economics.

---

Sources

[1] IQVIA, "Global API Market Report," 2022.
[2] U.S. Food and Drug Administration. "Drug Master Files," 2022.
[3] Knowledge from industry reports, 2023.